In vitro analysis demonstrates selected medicinal plants inhibit enzymes related to diabetes and obesity, suggesting potential therapies.
Key Points
Alhagi maurorum exhibited strong inhibitory activity against α-glucosidase, with an IC50 value of 45.16 µg/mL, highlighting its potential in diabetes treatment.
Crocus ancyrensis and Scabiosa rotata showed moderate α-amylase inhibition, with activities of 38.54% and 28.79%, respectively, indicating promising candidates for further study.
High levels of phenolics and flavonoids in Tilia tomentosa, Thymus praecox, and Berberis crataegina contributed to notable antioxidant activities, enhancing their therapeutic prospects.
Activity-guided fractionation of A. maurorum extract may lead to the discovery of new compounds with antidiabetic properties, emphasizing the need for further exploration.